Log in

NYSE:LLYEli Lilly And Co Stock Price, Forecast & News

$163.36
-3.09 (-1.86 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$162.74
Now: $163.36
$166.14
50-Day Range
$141.52
MA: $155.81
$169.13
52-Week Range
$101.36
Now: $163.36
$170.75
Volume2.25 million shs
Average Volume3.82 million shs
Market Capitalization$156.25 billion
P/E Ratio27.00
Dividend Yield1.81%
Beta0.26
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; and Avidity Biosciences, Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Read More
Eli Lilly And Co logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.7Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.01 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP53245710
Phone317-276-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$22.32 billion
Cash Flow$7.08 per share
Book Value$2.81 per share

Profitability

Net Income$8.32 billion

Miscellaneous

Employees33,625
Market Cap$156.25 billion
Next Earnings Date7/30/2020 (Confirmed)
OptionableOptionable

Receive LLY News and Ratings via Email

Sign-up to receive the latest news and ratings for LLY and its competitors with MarketBeat's FREE daily newsletter.

Eli Lilly And Co (NYSE:LLY) Frequently Asked Questions

How has Eli Lilly And Co's stock been impacted by COVID-19 (Coronavirus)?

Eli Lilly And Co's stock was trading at $140.02 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LLY shares have increased by 16.7% and is now trading at $163.36. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Eli Lilly And Co?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 4 hold ratings, 7 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Eli Lilly And Co.

When is Eli Lilly And Co's next earnings date?

Eli Lilly And Co is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for Eli Lilly And Co.

How can I listen to Eli Lilly And Co's earnings call?

Eli Lilly And Co will be holding an earnings conference call on Thursday, July 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Eli Lilly And Co's earnings last quarter?

Eli Lilly And Co (NYSE:LLY) issued its quarterly earnings data on Thursday, April, 23rd. The company reported $1.75 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.48 by $0.27. The company earned $5.86 billion during the quarter, compared to the consensus estimate of $5.48 billion. Eli Lilly And Co had a return on equity of 194.18% and a net margin of 23.97%. The firm's revenue was up 15.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.33 EPS. View Eli Lilly And Co's earnings history.

How often does Eli Lilly And Co pay dividends? What is the dividend yield for Eli Lilly And Co?

Eli Lilly And Co declared a quarterly dividend on Monday, May 4th. Stockholders of record on Friday, May 15th will be given a dividend of $0.74 per share on Wednesday, June 10th. This represents a $2.96 annualized dividend and a dividend yield of 1.81%. The ex-dividend date is Thursday, May 14th. View Eli Lilly And Co's dividend history.

What guidance has Eli Lilly And Co issued on next quarter's earnings?

Eli Lilly And Co issued an update on its FY20 earnings guidance on Thursday, April, 23rd. The company provided earnings per share guidance of $6.70-6.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.68. The company issued revenue guidance of $23.7-24.2 billion, compared to the consensus revenue estimate of $23.73 billion.

What price target have analysts set for LLY?

12 analysts have issued 12 month target prices for Eli Lilly And Co's shares. Their forecasts range from $148.00 to $190.00. On average, they expect Eli Lilly And Co's stock price to reach $169.73 in the next twelve months. This suggests a possible upside of 3.9% from the stock's current price. View analysts' price targets for Eli Lilly And Co.

Has Eli Lilly And Co been receiving favorable news coverage?

Media coverage about LLY stock has been trending negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Eli Lilly And Co earned a news impact score of -2.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View the latest news about Eli Lilly And Co.

Are investors shorting Eli Lilly And Co?

Eli Lilly And Co saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 6,000,000 shares, a decline of 18.8% from the June 15th total of 7,390,000 shares. Based on an average daily trading volume, of 4,080,000 shares, the short-interest ratio is presently 1.5 days. Currently, 0.7% of the company's stock are sold short. View Eli Lilly And Co's Current Options Chain.

Who are some of Eli Lilly And Co's key competitors?

What other stocks do shareholders of Eli Lilly And Co own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Intel (INTC), NVIDIA (NVDA), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Cisco Systems (CSCO), JPMorgan Chase & Co. (JPM), Merck & Co., Inc. (MRK) and AT&T (T).

Who are Eli Lilly And Co's key executives?

Eli Lilly And Co's management team includes the following people:
  • Mr. David A. Ricks, Chairman, CEO & Pres (Age 51)
  • Mr. Joshua L. Smiley, Sr. VP & CFO (Age 49)
  • Dr. Daniel M. Skovronsky, Sr. VP & Chief Scientific Officer (Age 45)
  • Mr. Michael J. Harrington, Sr. VP & Gen. Counsel (Age 56)
  • Mr. Jeffrey N. Simmons, Sr. VP & Pres of Elanco Animal Health (Age 52)

What is Eli Lilly And Co's stock symbol?

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Who are Eli Lilly And Co's major shareholders?

Eli Lilly And Co's stock is owned by many different institutional and retail investors. Top institutional investors include Hexavest Inc. (0.04%), Envestnet Asset Management Inc. (0.03%), State of Alaska Department of Revenue (0.02%), Manning & Napier Group LLC (0.02%), DNB Asset Management AS (0.01%) and Fulton Breakefield Broenniman LLC (0.01%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, David A Ricks, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill and Stephen F Fry. View institutional ownership trends for Eli Lilly And Co.

Which institutional investors are selling Eli Lilly And Co stock?

LLY stock was sold by a variety of institutional investors in the last quarter, including 6 Meridian, Gradient Investments LLC, First National Bank of Mount Dora Trust Investment Services, Park National Corp OH, Global Trust Asset Management LLC, TRUE Private Wealth Advisors, Cullinan Associates Inc., and Rockland Trust Co.. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Lilly Endowment Inc, Myles O'neill, and Stephen F Fry. View insider buying and selling activity for Eli Lilly And Co.

Which institutional investors are buying Eli Lilly And Co stock?

LLY stock was acquired by a variety of institutional investors in the last quarter, including Hexavest Inc., State of Alaska Department of Revenue, Manning & Napier Group LLC, DNB Asset Management AS, Fulton Bank N. A., Canandaigua National Corp, Sanders Morris Harris LLC, and Municipal Employees Retirement System of Michigan. Company insiders that have bought Eli Lilly And Co stock in the last two years include Anne E White, David A Ricks, Jackson P Tai, and Joshua L Smiley. View insider buying and selling activity for Eli Lilly And Co.

How do I buy shares of Eli Lilly And Co?

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Eli Lilly And Co's stock price today?

One share of LLY stock can currently be purchased for approximately $163.36.

How big of a company is Eli Lilly And Co?

Eli Lilly And Co has a market capitalization of $156.25 billion and generates $22.32 billion in revenue each year. The company earns $8.32 billion in net income (profit) each year or $6.04 on an earnings per share basis. Eli Lilly And Co employs 33,625 workers across the globe.

What is Eli Lilly And Co's official website?

The official website for Eli Lilly And Co is www.lilly.com.

How can I contact Eli Lilly And Co?

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.